Table 4.
Univariate regression and multivariate survival model of disease-specific survival in patients with LUAD.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | ||
| Pathologic stage | 483 | ||||
| Stage I and Stage II | 389 | ||||
| Stage III and Stage IV | 94 | 2.436 (1.645–3.605) | <0.001 | 1.319 (0.700–2.484) | 0.392 |
| T stage | 473 | ||||
| T1 | 168 | ||||
| T2 and T3 | 305 | 1.815 (1.169–2.819) | 0.008 | 1.652 (0.936–2.914) | 0.083 |
| N stage | 473 | ||||
| N0 | 327 | ||||
| N1 and N2 | 146 | 2.755 (1.909–3.975) | <0.001 | 2.059 (1.230–3.446) | 0.006 |
| M stage | 344 | ||||
| M0 | 323 | ||||
| M1 | 21 | 2.455 (1.269–4.749) | 0.008 | 1.782 (0.734–4.327) | 0.202 |
| Gender | 491 | ||||
| Female | 262 | ||||
| Male | 229 | 0.989 (0.687–1.424) | 0.954 | ||
| ESPL1 | 491 | 1.285 (1.097–1.504) | 0.002 | 1.219 (1.006–1.478) | 0.044 |